These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 9194767)
41. Combination treatment with an ET(A)-receptor blocker and an ACE inhibitor is not superior to the respective monotherapies in attenuating chronic transplant vasculopathy in different aorta allotransplantation rat models. Orth SR; Odoni G; Karkoszka H; Ogata H; Viedt C; Amann K; Ferrari P; Ritz E Nephrol Dial Transplant; 2003 Jan; 18(1):62-9. PubMed ID: 12480961 [TBL] [Abstract][Full Text] [Related]
42. Inhibitory effects of spironolactone on myocardial fibrosis in spontaneously hypertensive rats. Zhao H; Gu DW; Li HT; Ge QF; Li GP Genet Mol Res; 2015 Aug; 14(3):10315-21. PubMed ID: 26345970 [TBL] [Abstract][Full Text] [Related]
44. Transient prehypertensive treatment in spontaneously hypertensive rats: a comparison of losartan and amlodipine regarding long-term blood pressure, cardiac and renal protection. Peng F; Lin J; Lin L; Tang H Int J Mol Med; 2012 Dec; 30(6):1376-86. PubMed ID: 23064712 [TBL] [Abstract][Full Text] [Related]
45. Effects of the novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme, CGS 30440, on blood pressure and cardiac hypertrophy in spontaneously hypertensive rats. Webb RL; Abramson ML; Beil ME; Odorico LM; Chatelain RE J Cardiovasc Pharmacol; 1997 Nov; 30(5):632-42. PubMed ID: 9388046 [TBL] [Abstract][Full Text] [Related]
46. Induction of cardiac fibrosis by aldosterone. Lijnen P; Petrov V J Mol Cell Cardiol; 2000 Jun; 32(6):865-79. PubMed ID: 10888242 [TBL] [Abstract][Full Text] [Related]
47. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats. Takeda Y; Zhu A; Yoneda T; Usukura M; Takata H; Yamagishi M Am J Hypertens; 2007 Oct; 20(10):1119-24. PubMed ID: 17903697 [TBL] [Abstract][Full Text] [Related]
48. Withdrawal reveals lack of effect of prolonged antihypertensive treatment on intrinsic aortic wall stiffness in senescent spontaneously hypertensive rats. Marque V; Grima M; Kieffer P; Capdeville-Atkinson C; Atkinson J; Lartaud-Idjouadiene I Clin Exp Pharmacol Physiol; 2002 Oct; 29(10):898-904. PubMed ID: 12207569 [TBL] [Abstract][Full Text] [Related]
49. Chronic AT(1) blockade stimulates extracellular collagen type I degradation and reverses myocardial fibrosis in spontaneously hypertensive rats. Varo N; Iraburu MJ; Varela M; López B; Etayo JC; Díez J Hypertension; 2000 Jun; 35(6):1197-202. PubMed ID: 10856263 [TBL] [Abstract][Full Text] [Related]
50. [Spironolactone: renaissance of anti-aldosterone therapy in heart failure?]. Brilla CG; Schencking M; Scheer C; Rupp H Praxis (Bern 1994); 1997 Apr; 86(14):566-74. PubMed ID: 9198851 [TBL] [Abstract][Full Text] [Related]
51. [Antihypertensive activity of the angiotensin converting enzyme inhibitor quinapril HCl: (S)-2-[(S)-N-[(S)-1-ethoxycarbonyl-3-phenylpropyl) alanyl]-1,2,3,4- tetrahydro-3-isoquinolinecarboxylic acid monohydrochloride in various hypertensive animal models]. Yaoka O; Aoki K; Nakajima T; Setoguchi M Nihon Yakurigaku Zasshi; 1993 Jul; 102(1):35-45. PubMed ID: 8335286 [TBL] [Abstract][Full Text] [Related]